Citation Impact
Citing Papers
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2015
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
2016
Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
2016
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
2015
Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
2014
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
2019
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
2016
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Pancreatic cancer
2020 Standout
Tertiary lymphoid structures in cancer and beyond
2014
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Pancreatic cancer
2016 Standout
Hepatocellular carcinoma
2021 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Tertiary Lymphoid Tissue in the Tumor Microenvironment: From Its Occurrence to Immunotherapeutic Implications
2015
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
2014
The tumor microenvironment
2020 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
2015
Tertiary lymphoid structures in the era of cancer immunotherapy
2019
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Targeting neoantigens to augment antitumour immunity
2017
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Tumor Immunology and Tumor Evolution: Intertwined Histories
2020
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Renal cell carcinoma
2017 Standout
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
2016
B cells, plasma cells and antibody repertoires in the tumour microenvironment
2020
Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
2015
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
2019
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
2016
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
2019
Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation
2019
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
2015
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
2015
Genetics and biology of pancreatic ductal adenocarcinoma
2016
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
2015
Works of Allison Yager being referenced
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
2014
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
2013